Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Diroximel Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis: NEDA-3 after Re-Baselining in the Phase 3 EVOLVE-MS-1 Study

James D. Bowen,Jessica Stulc,Samuel F. Hunter,Hailu Chen,James B. Lewin,Matthew Scaramozza,Ivan Bozin,Florian Then Bergh

ADVANCES IN THERAPY（2024）

Cited 0|Views33
Key words
Multiple sclerosis,Disease-modifying therapies,Efficacy,No Evidence of Disease Activity (NEDA),Diroximel fumarate,Dimethyl fumarate,Re-baselining
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined